Skip to main content
Erschienen in: Neurological Sciences 3/2019

01.03.2019 | Letter to the Editor

Moyamoya masquerading as relapsing remitting multiple sclerosis

verfasst von: Sydney Feldman, Megan Esch, Shiv Saidha

Erschienen in: Neurological Sciences | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Excerpt

Dear Dr. Federico, …
Literatur
1.
Zurück zum Zitat Solomon AJ, Weinshenker BG (2013) Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention. Curr Neurol Neurosci Rep 13:403–409CrossRefPubMed Solomon AJ, Weinshenker BG (2013) Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention. Curr Neurol Neurosci Rep 13:403–409CrossRefPubMed
2.
Zurück zum Zitat Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173CrossRefPubMed Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173CrossRefPubMed
3.
Zurück zum Zitat Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, Galetta SL, Hutchinson M, Johnson RT, Kappos L, Kira J, Lublin FD, McFarland H, Montalban X, Panitch H, Richert JR, Reingold SC, Polman CH (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14:1157–1174CrossRefPubMedPubMedCentral Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, Freedman MS, Galetta SL, Hutchinson M, Johnson RT, Kappos L, Kira J, Lublin FD, McFarland H, Montalban X, Panitch H, Richert JR, Reingold SC, Polman CH (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14:1157–1174CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Guey S, Tournier-Lasserve E, Herve D, Kossorotoff M (2015) Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet 8:49–68PubMedPubMedCentral Guey S, Tournier-Lasserve E, Herve D, Kossorotoff M (2015) Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet 8:49–68PubMedPubMedCentral
5.
Zurück zum Zitat Fujiwara H, Momoshima S, Kuribayashi S (2005) Leptomeningeal high signal intensity (ivy sign) on fluid-attenuated inversion-recovery (FLAIR) MR images in moyamoya disease. Eur J Radiol 55:224–230CrossRefPubMed Fujiwara H, Momoshima S, Kuribayashi S (2005) Leptomeningeal high signal intensity (ivy sign) on fluid-attenuated inversion-recovery (FLAIR) MR images in moyamoya disease. Eur J Radiol 55:224–230CrossRefPubMed
6.
Zurück zum Zitat Putzki N, Katsarava Z (2010) Headache in multiple sclerosis. Curr Pain Headache 14:316–320CrossRef Putzki N, Katsarava Z (2010) Headache in multiple sclerosis. Curr Pain Headache 14:316–320CrossRef
7.
Zurück zum Zitat Kraemer M, Lee SI, Ayzenberg I, Schwitalla JC, Diehl RR, Berlit P, Bosche B, Katsarava Z, Obermann M (2017) Headache in Caucasian patients with Moyamoya angiopathy – a systematic cohort study. Cephalgia 37(5):496–500CrossRef Kraemer M, Lee SI, Ayzenberg I, Schwitalla JC, Diehl RR, Berlit P, Bosche B, Katsarava Z, Obermann M (2017) Headache in Caucasian patients with Moyamoya angiopathy – a systematic cohort study. Cephalgia 37(5):496–500CrossRef
8.
Zurück zum Zitat Dorfman LJ, Fischbein NJ, Woodard JI, Choudhri O, Bell-Stephens TE, Steinberg GK (2012) Moyamoya disease can masquerade as multiple sclerosis. Neurologist 18:398–403CrossRefPubMed Dorfman LJ, Fischbein NJ, Woodard JI, Choudhri O, Bell-Stephens TE, Steinberg GK (2012) Moyamoya disease can masquerade as multiple sclerosis. Neurologist 18:398–403CrossRefPubMed
9.
Zurück zum Zitat Starke RM, Crowley RW, Maltenfort M, Jabbour PM, Gonzalez LF, Tjoumakaris SI, Randazzo CG, Rosenwasser RH, Dumont AS (2012) Moyamoya disorder in the United States. Neurosurgery 71(1):93–99CrossRefPubMed Starke RM, Crowley RW, Maltenfort M, Jabbour PM, Gonzalez LF, Tjoumakaris SI, Randazzo CG, Rosenwasser RH, Dumont AS (2012) Moyamoya disorder in the United States. Neurosurgery 71(1):93–99CrossRefPubMed
10.
Zurück zum Zitat Plosker GL (2011) Interferon-β-1b: a review of its use in multiple sclerosis. CNS Drugs 25(1):67–88CrossRefPubMed Plosker GL (2011) Interferon-β-1b: a review of its use in multiple sclerosis. CNS Drugs 25(1):67–88CrossRefPubMed
Metadaten
Titel
Moyamoya masquerading as relapsing remitting multiple sclerosis
verfasst von
Sydney Feldman
Megan Esch
Shiv Saidha
Publikationsdatum
01.03.2019
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 3/2019
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-018-3615-8

Weitere Artikel der Ausgabe 3/2019

Neurological Sciences 3/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.